To further investigate the significance of the TNFα inhibition on the GL261 syngeneic glioma mouse model tumorigenesis, we used MP6-XT22, the TNFα monoclonal antibody derived from rat, which is an analog of Infliximab, a chimeric monoclonal antibody directed at TNFα [25, 25]. This evidence concerns the gene TNF and central nervous system cancer.